319 related articles for article (PubMed ID: 24251962)
1. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
Tang N; Zhao Y; Feng R; Liu Y; Wang S; Wei W; Ding Q; An MS; Wen J; Li L
J Cell Mol Med; 2014 Jan; 18(1):156-69. PubMed ID: 24251962
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of
Wen J; Lin X; Gao W; Qu B; Zuo Y; Liu R; Yu M
J Ocul Pharmacol Ther; 2019; 35(6):331-340. PubMed ID: 31343394
[No Abstract] [Full Text] [Related]
4. The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Funke M; Zhao Z; Xu Y; Chun J; Tager AM
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):355-64. PubMed ID: 22021336
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
[TBL] [Abstract][Full Text] [Related]
7. Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis.
Ashley SL; Wilke CA; Kim KK; Moore BB
Mucosal Immunol; 2017 Mar; 10(2):341-351. PubMed ID: 27435108
[TBL] [Abstract][Full Text] [Related]
8. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.
Wu Z; Yang L; Cai L; Zhang M; Cheng X; Yang X; Xu J
Respir Res; 2007 Jan; 8(1):1. PubMed ID: 17207287
[TBL] [Abstract][Full Text] [Related]
9. G-CSF Inhibits Pulmonary Fibrosis by Promoting BMSC Homing to the Lungs via SDF-1/CXCR4 Chemotaxis.
Zhao FY; Cheng TY; Yang L; Huang YH; Li C; Han JZ; Li XH; Fang LJ; Feng DD; Tang YT; Yue SJ; Tang SY; Luo ZQ; Liu W
Sci Rep; 2020 Jun; 10(1):10515. PubMed ID: 32601321
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome Proliferator-Activated Receptor Gamma Negatively Regulates the Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Toward Myofibroblasts in Liver Fibrogenesis.
Jia S; Liu X; Li W; Xie J; Yang L; Li L
Cell Physiol Biochem; 2015; 37(6):2085-100. PubMed ID: 26599535
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.
Bindu S; Pillai VB; Kanwal A; Samant S; Mutlu GM; Verdin E; Dulin N; Gupta MP
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L68-L78. PubMed ID: 27815257
[TBL] [Abstract][Full Text] [Related]
12. Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.
Cao P; Aoki Y; Badri L; Walker NM; Manning CM; Lagstein A; Fearon ER; Lama VN
J Clin Invest; 2017 Apr; 127(4):1517-1530. PubMed ID: 28240604
[TBL] [Abstract][Full Text] [Related]
13. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH
J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y
Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice.
Wang X; Zhao S; Lai J; Guan W; Gao Y
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008524
[TBL] [Abstract][Full Text] [Related]
17. LPA1 receptor activation promotes renal interstitial fibrosis.
Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow mesenchymal stromal cells attenuate silica-induced pulmonary fibrosis potentially by attenuating Wnt/β-catenin signaling in rats.
Zhang E; Yang Y; Chen S; Peng C; Lavin MF; Yeo AJ; Li C; Liu X; Guan Y; Du X; Du Z; Shao H
Stem Cell Res Ther; 2018 Nov; 9(1):311. PubMed ID: 30428918
[TBL] [Abstract][Full Text] [Related]
19. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
Ohashi T; Yamamoto T
Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
